ACLS · Axcelis Technologies Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $839.05M | $1.02B | $1.13B | $920.00M | $662.43M | $474.56M |
| Cost of Revenue | $462.20M | $563.21M | $639.30M | $518.21M | $375.98M | $275.98M |
| Gross Profit | $376.85M | $454.65M | $491.30M | $401.79M | $286.44M | $198.58M |
| R&D | $108.96M | $105.50M | $96.91M | $78.36M | $65.43M | $61.83M |
| SG&A | $83.21M | $70.32M | $65.79M | $57.47M | $46.14M | $39.96M |
| Total Operating Expenses | $257.53M | $243.86M | $225.51M | $189.43M | $159.12M | $140.54M |
| D&A | $17.61M | $15.81M | $13.07M | $11.61M | $10.82M | $9.94M |
| Operating Income | $119.31M | $210.79M | $265.80M | $212.36M | $127.33M | $58.04M |
| Interest Expense | $5.36M | $5.46M | $5.35M | $5.58M | $4.83M | $5.21M |
| Income Tax | $18.01M | $29.28M | $32.34M | $21.81M | $21.78M | $5.90M |
| Net Income | $200.99M | $200.99M | $246.26M | $183.08M | $98.65M | $49.98M |
| EPS - Basic | $3.81 | $6.17 | $7.52 | $5.54 | $2.94 | $1.50 |
| EPS - Diluted | $3.80 | $6.15 | $7.43 | $5.46 | $2.88 | $1.46 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $145.45M | $123.51M | $167.30M | $185.59M | $294.92M | $203.48M |
| Accounts Receivable | $168.48M | $203.15M | $217.96M | $169.77M | $104.41M | $86.86M |
| Inventory | $329.01M | $282.23M | $306.48M | $242.41M | $194.98M | $161.08M |
| Accounts Payable | $42.31M | $46.93M | $54.40M | $62.35M | $38.02M | $24.01M |
| Current Assets | $943.20M | $1.12B | $1.08B | $877.64M | $619.25M | $470.79M |
| Total Assets | $1.36B | $1.35B | $1.28B | $1.01B | $753.24M | $624.62M |
| Current Liabilities | $197.66M | $207.52M | $285.13M | $248.13M | $150.14M | $84.43M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $326.67M | $335.99M | $417.08M | $346.38M | $214.28M | $143.02M |
| Stockholders' Equity | $1.03B | $1.01B | $864.88M | $667.26M | $538.96M | $481.60M |
| Retained Earnings | $503.54M | $470.32M | $319.51M | $118.89M | ($22.72M) | ($91.97M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $118.31M | $140.82M | $156.87M | $215.61M | $150.19M | $69.70M |
| Investing Cash Flow | $29.93M | ($108.73M) | ($100.86M) | ($257.25M) | ($8.72M) | ($7.27M) |
| Financing Cash Flow | ($124.49M) | ($71.19M) | ($68.27M) | ($65.48M) | ($52.45M) | ($2.39M) |
| CapEx | $11.29M | $12.18M | $20.66M | $10.68M | $8.72M | $7.43M |
| Free Cash Flow | $107.01M | $128.64M | $136.21M | $204.92M | $141.47M | $62.27M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 44.9% | 44.7% | 43.5% | 43.7% | 43.2% | 41.8% |
| Operating margin | 14.2% | 20.7% | 23.5% | 23.1% | 19.2% | 12.2% |
| EBITDA margin | 16.3% | 22.3% | 24.7% | 24.3% | 20.9% | 14.3% |
| Net margin | 24.0% | 19.7% | 21.8% | 19.9% | 14.9% | 10.5% |
| Free cash flow margin | 12.8% | 12.6% | 12.0% | 22.3% | 21.4% | 13.1% |
| FCF / Net income | 0.53 | 0.64 | 0.55 | 1.12 | 1.43 | 1.25 |
| R&D / Revenue | 13.0% | 10.4% | 8.6% | 8.5% | 9.9% | 13.0% |
| SG&A / Revenue | 9.9% | 6.9% | 5.8% | 6.2% | 7.0% | 8.4% |
| Effective tax rate | 8.2% | 12.7% | 11.6% | 10.6% | 18.1% | 10.6% |
| Return on assets | 14.8% | 14.9% | 19.2% | 18.1% | 13.1% | 8.0% |
| Return on equity | 19.4% | 19.8% | 28.5% | 27.4% | 18.3% | 10.4% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 4.77 | 5.41 | 3.79 | 3.54 | 4.12 | 5.58 |
| Quick ratio | 3.11 | 4.05 | 2.71 | 2.56 | 2.83 | 3.67 |
| Cash ratio | 0.74 | 0.60 | 0.59 | 0.75 | 1.96 | 2.41 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 22.2x | 38.6x | 49.7x | 38.1x | 26.3x | 11.1x |
| Equity multiplier | 1.32 | 1.33 | 1.48 | 1.52 | 1.40 | 1.30 |
| Liabilities / Assets | 0.24 | 0.25 | 0.33 | 0.34 | 0.28 | 0.23 |
| Efficiency | ||||||
| Asset turnover | 0.62 | 0.75 | 0.88 | 0.91 | 0.88 | 0.76 |
| Inventory turnover | 1.40 | 2.00 | 2.09 | 2.14 | 1.93 | 1.71 |
| Days sales outstanding | 73d | 73d | 70d | 67d | 58d | 67d |
| Days inventory outstanding | 260d | 183d | 175d | 171d | 189d | 213d |
| Days payable outstanding | 33d | 30d | 31d | 44d | 37d | 32d |
| Cash conversion cycle | 300d | 225d | 214d | 194d | 210d | 248d |
| Valuation | ||||||
| P / E | 21.1x | 11.4x | 17.5x | 14.5x | 25.9x | 19.9x |
| P / B | 2.5x | 2.3x | 5.0x | 4.0x | 4.7x | 2.1x |
| P / S | 3.0x | 2.2x | 3.8x | 2.9x | 3.9x | 2.1x |
| EV / EBITDA | 17.5x | 9.5x | 14.8x | 11.1x | 16.4x | 11.6x |
| Growth | ||||||
| Revenue growth (YoY) | -17.6% | -10.0% | 22.9% | 38.9% | 39.6% | 38.4% |
| Revenue CAGR (3y) | -3.0% | 15.4% | 33.6% | 38.9% | 35.4% | 4.9% |
| Revenue CAGR (5y) | 12.1% | 24.3% | 33.5% | 17.5% | 19.9% | 9.5% |
| Gross profit growth (YoY) | -17.1% | -7.5% | 22.3% | 40.3% | 44.2% | 37.8% |
| Operating income growth (YoY) | -43.4% | -20.7% | 25.2% | 66.8% | 119.4% | 139.8% |
| Net income growth (YoY) | 0.0% | -18.4% | 34.5% | 85.6% | 97.4% | 193.4% |
| EPS growth (YoY) | -38.2% | -17.2% | 36.1% | 89.6% | 97.3% | 192.0% |
| EPS CAGR (3y) | -11.4% | 28.8% | 72.0% | 121.9% | 28.7% | -27.3% |
| EPS CAGR (5y) | 21.1% | 65.2% | 40.6% | 7.5% | 51.6% | 64.8% |
| FCF growth (YoY) | -16.8% | -5.6% | -33.5% | 44.9% | 127.2% | - |
| FCF CAGR (5y) | 11.4% | - | 26.4% | - | - | 30.5% |
| Book value growth (YoY) | 2.2% | 17.1% | 29.6% | 23.8% | 11.9% | 14.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$839.05M totalSingle Reportable Segment$839.05M · 100.0%
Product / service
$2.52B totalIon Implantation Systems Services And Royalties$824.10M · 32.7%
Product$792.04M · 31.5%
New Systems Revenue$571.02M · 22.7%
After Market$268.03M · 10.6%
Services$47.00M · 1.9%
Other Products Systems Services And Royalties$14.95M · 0.6%
Geographic
$1.68B totalNon Us$702.00M · 41.8%
US$482.64M · 28.8%
Asia Pacific$306.45M · 18.3%
North America$137.08M · 8.2%
Europe$49.95M · 3.0%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.92
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Special Industry Machinery, NEC
Comparing AXCELIS TECHNOLOGIES INC against the 5 most active filers in the same SIC group.